Each batch of KLOW is manufactured under controlled conditions and subjected to comprehensive quality control testing, including peptide content verification, sterility screening, and endotoxin analysis
A poster presentation at the 2023 International Conference on Alzheimers and Parkinsons Diseases and Related Neurological Disorders (AD/PD) highlighted positive results from one such trial, the Phase II ELAD study, which assessed Novo Nordisks liraglutide in mild to moderate Alzheimers
Finally, the selection scope was limited to randomized controlled trials
Control groups during this phase received distilled water [2]
Smith, J
Despite the absence of adverse cardiovascular effects has been confirmed, this benefit was not verified in an integrated analysis of 12 controlled, randomized, short-term clinical trials (12-52 weeks) comparing exenatide with placebo or insulin [72]